“Association of Serum High Sensitivity C-Reactive Protein with Insulin Resistance in Patients with Type-ΙΙ Diabetes Mellitus”, Eastern Med. Coll. J., vol. 7, no. 1, pp. 15–20, Nov. 2022, doi: 10.3329/emcj.v7i1.62721.